Recent Advances on Nanomaterials to COVID-19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS-CoV-2 Inhibition/Inactivation

Nanomaterials can be effectively used to detect, capture/inactivate, or inhibit coronavirus cell entry/replication. Nano carbons, biopolymeric, copper...

A systematic review and meta-analysis of obesity and COVID-19 outcomes

Some studies report that obesity is associated with more severe symptoms following SARS-CoV-2 infection and worse COVID-19 outcomes. It is uncertain w...

Covaxin may face hurdles post Brazil’s move to halt its import

Bharat Biotech International's Covaxin was refused an emergency use licence in Brazil due to suspected serious lapses at its Hyderabad plant. Other he...

Points To Emphasis About Covid 19 Vaccine | Dr. Abdul Khaliq

The vaccine will help to prevent or reduce significantly death rate. the vaccine will reduce the severity of the disease if you get infected by the v...

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Severe COVID-19 is characterized by inflammation and coagulation in the presence of complement system activation. We aimed to explore the potential be...

Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease accounting for 1% of UK deaths. Short telomere length is associated with IPF and chronic o...

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

Biological considerations suggest that renin-angiotensin system inhibitors might influence the severity COVID-19 Replace trial was a prospective, open...

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

ANDHI was done to assess the efficacy of bevacizumab in treating severe eosinophilic asthma. It was a randomized, double-blind, parallel-group, placeb...

Departments

Recent Posts